Friday, September 23, 2016 11:43:21 PM
anyway.. i always worry when literally everyone is bullish and thinks its a sure bet --- (im strictly referring to super short term)
i liekd it better when I was one of the few :p
Recent NVAX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 12:57:59 AM
- Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer • IH Market News • 01/20/2026 02:48:06 PM
- Novavax Announces Entering into a License Agreement with Pfizer • PR Newswire (US) • 01/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 11:59:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:01:06 PM
- Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/07/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2025 09:01:11 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/12/2025 09:17:57 PM
- Novavax to Participate in Jefferies London Healthcare Conference • PR Newswire (US) • 11/12/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 01:00:22 PM
- Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights • PR Newswire (US) • 11/06/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 12:47:47 PM
- Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment • PR Newswire (US) • 11/04/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 11:02:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 08:30:19 PM
- Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 • PR Newswire (US) • 10/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 11:00:50 AM
- Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy • PR Newswire (US) • 10/22/2025 11:00:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/14/2025 11:45:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 11:00:33 AM
- Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment • PR Newswire (US) • 10/07/2025 11:00:00 AM
- Novavax Announces Progress on Sanofi Agreement • PR Newswire (US) • 09/30/2025 01:01:00 PM
- Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment • PR Newswire (US) • 09/04/2025 12:00:00 PM
- Novavax to Participate in the Cantor Global Healthcare Conference • PR Newswire (US) • 09/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:40:29 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
